AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab plus Carboplatin as 1L Treatment of Advanced/mNSCLC

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAGGARWAL, C.
dc.contributor.authorCHEEMA, P.
dc.contributor.authorARRIETA, O.
dc.contributor.authorBONANNO, L.
dc.contributor.authorBORGHAEI, H.
dc.contributor.authorHU, Y.
dc.contributor.authorKIM, D. -W.
dc.contributor.authorCASTRO JUNIOR, G. de
dc.contributor.authorHEPNER, A.
dc.contributor.authorDENG, C.
dc.contributor.authorRIEGO, M. Gonzalez del
dc.contributor.authorKATO, T.
dc.date.accessioned2024-03-08T15:15:04Z
dc.date.available2024-03-08T15:15:04Z
dc.date.issued2023
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.identifier.citationJOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S305-S306, 2023
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/58527
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofJournal of Thoracic Oncology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.subjectDatopotamab deruxtecaneng
dc.subjectTROP2eng
dc.subjectDurvalumabeng
dc.subject.wosOncologyeng
dc.subject.wosRespiratory Systemeng
dc.titleAVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab plus Carboplatin as 1L Treatment of Advanced/mNSCLCeng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryJapão
hcfmusp.affiliation.countryCoréia do Sul
hcfmusp.affiliation.countryChina
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryMéxico
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoca
hcfmusp.affiliation.countryisomx
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisocn
hcfmusp.affiliation.countryisokr
hcfmusp.affiliation.countryisojp
hcfmusp.author.externalAGGARWAL, C.:Univ Penn, Philadelphia, PA 19104 USA
hcfmusp.author.externalCHEEMA, P.:William Osler Hlth Syst, Brampton, ON, Canada
hcfmusp.author.externalARRIETA, O.:Inst Nacl Cancerol, Mexico City, DF, Mexico
hcfmusp.author.externalBONANNO, L.:Ist Oncol Veneto IOV IRCCS, Padua, Italy
hcfmusp.author.externalBORGHAEI, H.:Fox Chase Canc Ctr, Philadelphia, PA USA
hcfmusp.author.externalHU, Y.:Peoples Liberat Army China Gen Hosp, Beijing, Peoples R China
hcfmusp.author.externalKIM, D. -W.:Seoul Natl Univ Hosp, Seoul, South Korea
hcfmusp.author.externalHEPNER, A.:AstraZeneca, Gaithersburg, MD USA
hcfmusp.author.externalDENG, C.:AstraZeneca, Waltham, MA USA
hcfmusp.author.externalRIEGO, M. Gonzalez del:AstraZeneca, Gaithersburg, MD USA
hcfmusp.author.externalKATO, T.:Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.description.beginpageS305
hcfmusp.description.endpageS306
hcfmusp.description.issue11
hcfmusp.description.issuesuppl S
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:001098831600507
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication.latestForDiscovery0df25c0f-1337-424e-b0f7-41d0fccb51fc
Arquivos
Coleções
Comunicações em Eventos - HC/ICESP
Comunicações em Eventos - LIM/24